Most investors are probably well-aware that the financial markets and investing strategies have become increasingly complex in recent years. Hedge funds have turned to derivatives, interest rate swaps, credit default swaps, packaged mortgages, and other very confusing and complicated instruments to hedge their positions and make 'alpha.'
But as we're seeing recently, more complicated doesn't always mean better, especially in the financial markets. The Financial Times Alphaville Blog recently had an interesting post about this very issue. In fact, this post even drew on biology to explain why simple is better than complex: "Animals that have become more complex, adapting better to their environments, "enjoy greater success for a while, but are less likely to withstand a catastrophe." Sounds familiar, no?
In fact, the blogger goes on to assert that a "crude strategy" such as sticking to stocks, bonds and cash is "more likely to survive a change in the environment." This makes perfect sense, especially for individual investors. For more than half of individual investors (those without the adequate time to research) the crudest investment strategy of all -- buying and holding index funds -- makes the most sense.
Hedge fund investors are going to want to understand what they own if they are blown out. When they realize that exorbitant leverage is primarily the culprit for their weak performance their going to demand lower leverage. When they realize that many of their positions make absolutely no sense to 95% of America, they're going to demand simplicity. As the markets continue to evolve I wouldn't doubt a regression to simpler, more easily understood investments.
Last updated: February 13, 2012: 02:50 PM
Hot Stocks
DailyFinance Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
Benzinga Headlines
- Military Budget Cuts Hit These Contractors
- Earnings Preview: Tesla Hoping to Retain its Drive
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
TheFlyOnTheWall.com Headlines
- NTS, Inc. announces $1.35M bond buyback plan
- Jabil Circuit target raised to $32 from $24 at Argus
- NYSE market internals summary
- NASDAQ market internals summary
- Honda looks to double car production in Europe, Financial Times reports
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore

